ZILTANCA Trademark

Trademark Overview

On Tuesday, July 24, 2012, a trademark application was filed for ZILTANCA with the United States Patent and Trademark Office. The USPTO has given the ZILTANCA trademark a serial number of 79116348. The federal status of this trademark filing is IR CANCELLED - US REGISTRATION CANCELLED as of Sunday, July 24, 2022. This trademark is owned by Boehringer Ingelheim International GmbH. The ZILTANCA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of diseases and disorders of the alimentary tract and metabolism, and blood and blood forming organs; pharmaceutical preparations for the treatment of diseases and disorders of the cardiovascular system, musculoskeletal system, central nervous system, peripheral nervous system, genitourinary system and respiratory system; and pharmaceutical preparations for the treatment of dermatological, hormonal, infectious, viral and oncological diseases and disorders
ziltanca

General Information

Serial Number79116348
Word MarkZILTANCA
Filing DateTuesday, July 24, 2012
Status404 - IR CANCELLED - US REGISTRATION CANCELLED
Status DateSunday, July 24, 2022
Registration Number4326429
Registration DateTuesday, April 30, 2013
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 12, 2013

Trademark Statements

Goods and ServicesPharmaceutical preparations, namely, pharmaceutical preparations for the treatment of diseases and disorders of the alimentary tract and metabolism, and blood and blood forming organs; pharmaceutical preparations for the treatment of diseases and disorders of the cardiovascular system, musculoskeletal system, central nervous system, peripheral nervous system, genitourinary system and respiratory system; and pharmaceutical preparations for the treatment of dermatological, hormonal, infectious, viral and oncological diseases and disorders

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status CodeF - NOT AVAILABLE
Class Status DateFriday, December 6, 2019
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameBoehringer Ingelheim International GmbH
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressDE
Party NameBoehringer Ingelheim International GmbH
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressDE
Party NameBoehringer Ingelheim International GmbH
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressDE

Trademark Events

Event DateEvent Description
Friday, March 10, 2023UNDELIVERABLE MAIL - NO ACTION TAKEN
Sunday, February 19, 2023NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED
Sunday, February 19, 2023DEATH OF INTERNATIONAL REGISTRATION
Saturday, October 10, 2020TOTAL INVALIDATION PROCESSED BY THE IB
Monday, September 14, 2020TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Monday, September 14, 2020INVALIDATION PROCESSED
Thursday, August 6, 2020TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Friday, December 6, 2019CANCELLED SECTION 71
Saturday, August 17, 2013FINAL DECISION TRANSACTION PROCESSED BY IB
Wednesday, July 31, 2013FINAL DISPOSITION NOTICE SENT TO IB
Wednesday, July 31, 2013FINAL DISPOSITION PROCESSED
Tuesday, July 30, 2013FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, April 30, 2013REGISTERED-PRINCIPAL REGISTER
Tuesday, February 26, 2013NOTIFICATION PROCESSED BY IB
Tuesday, February 12, 2013PUBLISHED FOR OPPOSITION
Wednesday, January 23, 2013NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, January 23, 2013NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, January 23, 2013NOTICE OF PUBLICATION
Wednesday, January 9, 2013LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, January 2, 2013APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, December 20, 2012AMENDMENT FROM APPLICANT ENTERED
Thursday, December 20, 2012CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, December 12, 2012ASSIGNED TO LIE
Monday, December 10, 2012PAPER RECEIVED
Thursday, November 15, 2012REFUSAL PROCESSED BY IB
Wednesday, November 14, 2012TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, October 22, 2012NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Monday, October 22, 2012REFUSAL PROCESSED BY MPU
Monday, October 22, 2012NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Sunday, October 21, 2012NON-FINAL ACTION WRITTEN
Wednesday, October 17, 2012ASSIGNED TO EXAMINER
Wednesday, September 5, 2012APPLICATION FILING RECEIPT MAILED
Saturday, September 1, 2012NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, August 31, 2012LIMITATION FROM ORIGINAL APPLICATION ENTERED
Thursday, August 30, 2012SN ASSIGNED FOR SECT 66A APPL FROM IB

Related Keywords

ziltanca system pharmaceutical preparations diseases disorders treatment blood nervous peripheral genitourinary